Dipeptidyl Peptidase-4 Inhibitors, Peripheral Arterial Disease, and Lower Extremity Amputation Risk in Diabetic Patients Chun-Chin Chang, MD, Yung-Tai Chen, MD, Chien-Yi Hsu, MD, Yu-Wen Su, MD, Chun-Chih Chiu, MD, Hsin-Bang Leu, MD, PhD, Po- Hsun Huang, MD, PhD, Jaw-Wen Chen, MD, PhD, Shing-Jong Lin, MD, PhD The American Journal of Medicine Volume 130, Issue 3, Pages 348-355 (March 2017) DOI: 10.1016/j.amjmed.2016.10.016 Copyright © 2016 Elsevier Inc. Terms and Conditions
Figure Flow diagram of study selection process. DPP-IV = dipeptidyl peptidase-4; T2DM = type 2 diabetes mellitus. The American Journal of Medicine 2017 130, 348-355DOI: (10.1016/j.amjmed.2016.10.016) Copyright © 2016 Elsevier Inc. Terms and Conditions